Scarica l'app Stockscreener
6.98
7.06%
0.46
Pre-mercato:
7.01
0.03
+0.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IOVA Giù?
Forum
Previsione
Frazionamento azionario
Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie
GSA Capital Partners LLP Buys New Holdings in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Bank of America Corp DE Sells 5,787,694 Shares of Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics, Inc. stock Analysis: 130% Rally & Overbought Signals 2026 - The Cryptonomist
IOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - Stocktwits
After IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - Stocktwits
Is Iovance Biotherapeutics (IOVA) Undervalued As Q2 Earnings Reaffirm Revenue Guidance? - Yahoo Finance
Iovance (IOVA) Q2 2026 Earnings Call Transcript - AOL.com
IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock Chart - ChartMill
Iovance Biotherapeutics (NASDAQ:IOVA) Sets New 12-Month HighHere's What Happened - MarketBeat
Iovance Biotherapeutics stock hits 52-week high at 6.94 USD By Investing.com - Investing.com Nigeria
Iovance Biotherapeutics stock hits 52-week high at 6.94 USD - Investing.com
Iovance Biotherapeutics Inc (IOVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Iovance Biotherapeutics, Inc. (IOVA) Latest Stock News & Headlines - Yahoo Finance
IOVA Stock Quote Price and Forecast - CNN
IOVA Stock Price Prediction 2025-2026 | Iovance Biotherapeutics Inc Forecast - 24/7 Wall St.
Iovance Biotherapeutics (IOVA) Is Up 48.3% After Narrowing Losses And Reaffirming 2026 Revenue Guidance - Sahm
Iovance Biotherapeutics (IOVA) Stock Looks Fairly Valued Despite 222% Returns - Sahm
Hennion & Walsh Asset Management Inc. Grows Stock Position in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics (IOVA) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Is Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance? - Sahm
Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher? - The Motley Fool
Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher? - The Motley Fool
Why Is Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Back in Market Conversation? - Kalkine Media
Weekly Recap: IOV-LUN-202 enrollment and Q2 2026 revenue jump - TradingView
Dimensional Fund Advisors LP Purchases 1,106,592 Shares of Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
What is HC Wainwright's Forecast for IOVA Q3 Earnings? - MarketBeat
Earnings Beat: Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Moomoo
Iovance Biotherapeutics (NASDAQ:IOVA) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Iovance Biotherapeutics Stock Price Forecast. Should You Buy IOVA? - StockInvest.us
Iovance Biotherapeutics (NASDAQ:IOVA) Given New $8.00 Price Target at Citizens Jmp - MarketBeat
$Iovance Biotherapeutics (IOVA.US)$ - Moomoo
State Street Corporation (NYSE: STT) discloses 5.5% Iovance Biotherapeutics stake - Stock Titan
Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect? - Yahoo Finance
A Quick Look at Today's Ratings for Iovance Biotherapeutics(IOVA.US), With a Forecast Between $7 to $13 - Moomoo
Iovance Biotherapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Form 8K Iovance Biotherapeutics Inc For: 6 August By Investing.com - Investing.com South Africa
Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 44.93% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Iovance Biotherapeutics Inc (IOVA) Stock News Today - TradingKey
Iovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highl - GuruFocus
Iovance Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $8.67, Implies 100% Upside - TradingView
Iovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Iovance Biotherapeutics stock hits 52-week high at $5.97 By Investing.com - Investing.com Nigeria
Iovance Biotherapeutics (NASDAQ: IOVA) files updated August 2026 presentation - Stock Titan
Iovance Biotherapeutics Q2 Earnings Call Highlights - MarketBeat
Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here’s What Comes Next - Yahoo Finance
IovanceStock Soars On Q2 EarningsCritical Data In Melanoma, NSCLC Due September - Seeking Alpha
Iovance Biotherapeutics (IOVA) Shares Surge 40% on Strong Q2; Ma - GuruFocus
Earnings call transcript: Iovance beats Q2 2026 estimates, shares jump 30% - Investing.com
Iovance shares surge 39% as Amtagvi Q2 revenue and margins surpass expectations - TechStock²
Iovance Biotherapeutics (IOVA) Revises 2026 Revenue Outlook Amid Strong Q2 Sales - GuruFocus
Why Iovance Biotherapeutics (IOVA) Stock Is Up Today - Quiver Quantitative
Stock Traders Buy Large Volume of Call Options on Iovance Biotherapeutics (NASDAQ:IOVA) - MarketBeat
Iovance Biotherapeutics (NASDAQ:IOVA) Sets New 52-Week High on Strong Earnings - MarketBeat
Iovance Biotherapeutics stock hits 52-week high at $5.97 - Investing.com
Iovance Biotherapeutics Reports Record Q2 Revenue and Reviews 2026 Outlook on Strong Amtagvi Demand - Yahoo Finance
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Iovance Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
IOVANCE BIOTHERAPEUTICS, INC. 2Q 2026: Revenue $99.3M, EPS $(0.11) — 10-Q Summary - TradingView
IOVA Stock Grants Signal Aggressive Post-Amtagvi Expansion - StocksToTrade
Iovance Biotherapeutics (NASDAQ: IOVA) posts Q2 2026 $99.3M revenue - Stock Titan
Earnings Flash (IOVA) Iovance Biotherapeutics Posts Q2 Loss $0.11 a Share, vs. FactSet Est of $0.13 Loss - marketscreener.com
Is Iovance Biotherapeutics (IOVA) Positioned for Growth After Q2 - GuruFocus
Earnings Flash (IOVA) Iovance Biotherapeutics, Inc. Reports Q2 Revenue $99.3M, vs. FactSet Est of $87.8M - marketscreener.com
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):